Skip to main content


Table 3 Hazard ratio of each metabolic phenotype for incident gastric cancer

From: Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study

 Impaired fasting plasma glucose and/or diabetes (−)Impaired fasting plasma glucose and/or diabetes (+)
Person-year, n85,934.9434,455.79
Incident cases, n3840
Incidence rate per 1000 person-years0.441.16
Crude modelRef2.67 (1.71–4.17), p < 0.001
 Hypertension (−)Hypertension (+)
Person-year, n91,735.728,655
Incident cases, n4632
Incidence rate per 1000 person-years0.501.12
Crude modelRef2.28 (1.44–3.56), p < 0.001
 Elevated triglycerides (−)Elevated triglycerides (+)
Person-year, n104,57215,818.4
Incident cases, n6216
Incidence rate per 1000 person-years0.591.01
Crude modelRef1.69 (0.94–2.85), p = 0.077
 Low HDL-cholesterol (−)Low HDL-cholesterol (+)
Person-year, n93,354.827,036
Incident cases, n5523
Incidence rate per 1000 person-years0.590.86
Crude modelRef1.41 (0.85–2.26), p = 0.180
  1. HDL High-density lipoprotein